Selection against Pathogenic mtDNA Mutations in a Stem Cell Population Leads to the Loss of the 3243A→G Mutation in Blood

Virginia Bioinformatics Institute, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA.
The American Journal of Human Genetics (Impact Factor: 10.99). 02/2008; 82(2):333-43. DOI: 10.1016/j.ajhg.2007.10.007
Source: PubMed

ABSTRACT The mutation 3243A-->G is the most common heteroplasmic pathogenic mitochondrial DNA (mtDNA) mutation in humans, but it is not understood why the proportion of this mutation decreases in blood during life. Changing levels of mtDNA heteroplasmy are fundamentally related to the pathophysiology of the mitochondrial disease and correlate with clinical progression. To understand this process, we simulated the segregation of mtDNA in hematopoietic stem cells and leukocyte precursors. Our observations show that the percentage of mutant mtDNA in blood decreases exponentially over time. This is consistent with the existence of a selective process acting at the stem cell level and explains why the level of mutant mtDNA in blood is almost invariably lower than in nondividing (postmitotic) tissues such as skeletal muscle. By using this approach, we derived a formula from human data to correct for the change in heteroplasmy over time. A comparison of age-corrected blood heteroplasmy levels with skeletal muscle, an embryologically distinct postmitotic tissue, provides independent confirmation of the model. These findings indicate that selection against pathogenic mtDNA mutations occurs in a stem cell population.

Download full-text


Available from: David Samuels, Aug 24, 2015
  • Source
    • "In the NZB mouse model, the rate of selection is currently held to be independent of initial heteroplasmy, and constant with time (Battersby et al., 2003). The human A3243G mtDNA mutation is lost continually from the blood of patients (Rahman et al., 2001; Rajasimha et al., 2008). To find out whether mtDNA dynamics change during organismal development or stay constant at all times, we applied an appropriate population genetic model for mtDNA segregation in our data. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The dynamics by which mitochondrial DNA (mtDNA) evolves within organisms are still poorly understood, despite the fact that inheritance and proliferation of mutated mtDNA cause fatal and incurable diseases. When two mtDNA haplotypes are present in a cell, it is usually assumed that segregation (the proliferation of one haplotype over another) is negligible. We challenge this assumption by showing that segregation depends on the genetic distance between haplotypes. We provide evidence by creating four mouse models containing mtDNA haplotype pairs of varying diversity. We find tissue-specific segregation in all models over a wide range of tissues. Key findings are segregation in postmitotic tissues (important for disease models) and segregation covering all developmental stages from prenatal to old age. We identify four dynamic regimes of mtDNA segregation. Our findings suggest potential complications for therapies in human populations: we propose "haplotype matching" as an approach to avoid these issues.
  • Source
    • "Mutation load in several easily accessible tissues must be considered. Since mtDNA heteroplasmy may change with age in blood [8]. This is partly supported by our findings of motor-predominant axonal neuropathy in mother of our patient in whom heteroplasmy level was found within interval of 68–96% (blood-hair follicles) in contrast with totally asymptomatic mother from previous case harboring higher mutation load (85%) in blood, however other tissues remained uninvestigated. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We report the second known family with a very rare, maternally inherited missense m.8851T>C mutation in the mitochondrial MTATP6 gene. A failure to thrive, microcephaly, psychomotor retardation and hypotonia were present in a 3-year-old girl with a high mtDNA mutation load (87-97%). Ataxia and Leigh syndrome were subsequently documented in a neurological examination and brain MRI. A muscle biopsy demonstrated decreased ATP synthase and an accumulation of succinate dehydrogenase products, indicating mitochondrial myopathy. Her 36-year-old mother (68% blood heteroplasmy) developed peripheral neuropathy and muscle weakness at the age of 22years. Our findings extend the clinical and laboratory phenotype associated with the m.8851T>C mutation.
    Molecular Genetics and Metabolism 11/2012; 108(1). DOI:10.1016/j.ymgme.2012.11.002 · 2.83 Impact Factor
  • Source
    • "This tissue dependance has been suggested to result from a replicative disadvantage of cells harboring a high mutant load, thus promoting ''mutation epuration'' from fast regenerating tissues. Should such a biological process operate prenatally, it could be missed out within the ''short'' course of a pregnancy, by reference to the very slow decrease of mean mutation level in adult white blood cells [Rajasimha et al., 2008], thus reflecting the apparent intertissue mutant load stability throughout the prenatal period. Alternatively, cell proliferation rate would be identical among all tissues throughout intrauterine life, and would become tissue dependent from a fairly late postnatal period. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mitochondrial DNA (mtDNA) mutations cause a wide range of serious diseases with high transmission risk and maternal inheritance. Tissue heterogeneity of the heteroplasmy rate ("mutant load") accounts for the wide phenotypic spectrum observed in carriers. Owing to the absence of therapy, couples at risk to transmit such disorders commonly ask for prenatal (PND) or preimplantation diagnosis (PGD). The lack of data regarding heteroplasmy distribution throughout intrauterine development, however, hampers the implementation of such procedures. We tracked the segregation of the m.3243A>G mutation (MT-TL1 gene) responsible for the MELAS syndrome in the developing embryo/fetus, using tissues and cells from eight carrier females, their 38 embryos and 12 fetuses. Mutant mtDNA segregation was found to be governed by random genetic drift, during oogenesis and somatic tissue development. The size of the bottleneck operating for m.3243A>G during oogenesis was shown to be individual-dependent. Comparison with data we achieved for the m.8993T>G mutation (MT-ATP6 gene), responsible for the NARP/Leigh syndrome, indicates that these mutations differentially influence mtDNA segregation during oogenesis, while their impact is similar in developing somatic tissues. These data have major consequences for PND and PGD procedures in mtDNA inherited disorders.
    Human Mutation 01/2011; 32(1):116-25. DOI:10.1002/humu.21417 · 5.05 Impact Factor
Show more